David Rosmarin

16PUBLICATIONS
40CO-AUTHORS
Pharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)Photography, video and lens-based practiceRadiation therapyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Nov 10, 2025
Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publication.

David Rosmarin, Thierry Passeron, Amit G Pandya

|Mar 29, 2025
Efficacy and Safety of Ruxolitinib Cream in Vitiligo by Patient Characteristic Subgroups: Descriptive Pooled Analysis From Two Phase 3 Studies.

Julien Seneschal, Albert Wolkerstorfer, Seemal R Desai

|Dec 03, 2024
Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years.

John E Harris, Amit G Pandya, Mark Lebwohl

|Oct 17, 2024
Incidence of nonmelanoma skin cancer in patients with vitiligo who applied ruxolitinib cream.

Khaled Ezzedine, Albert Wolkerstorfer, Shaoceng Wei

|Sep 19, 2024
Coverage of Specialty Drugs for Psoriasis and Psoriatic Arthritis by Commercial Insurance Companies.

Christine Learned, Sara Alsukait, Kristin R Fiumara

|Aug 13, 2024
Healthcare Resource Use and Costs Among Individuals with Vitiligo and Psychosocial Comorbidities: Retrospective Analysis of an Insured US Population.

Jennifer H Lofland, Samyuktha Darbha, Ahmad B Naim

Pageof 3

Frequent Collaborators

4 joint publications

Deanna Kornacki

3 joint publications

Amit G Pandya

3 joint publications

Pearl Grimes

3 joint publications

Khaled Ezzedine